Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis

Abstract
No abstract available
Funding Information
  • Janssen Pharmaceuticals and Prometheus Laboratories
  • Sandford J. Grossman Charitable Trust